| International cooperation to enable the diagnosis of all rare genetic diseases KM Boycott, A Rath, JX Chong, T Hartley, FS Alkuraya, G Baynam, ... The American Journal of Human Genetics 100 (5), 695-705, 2017 | 398 | 2017 |
| Outcome of renal transplantation in patients with non–shiga toxin–associated hemolytic uremic syndrome: prognostic significance of genetic background E Bresin, E Daina, M Noris, F Castelletti, R Stefanov, P Hill, THJ Goodship, ... Clinical Journal of the American Society of Nephrology 1 (1), 88-99, 2006 | 269 | 2006 |
| National plans and strategies on rare diseases in Europe D Taruscio, L Vittozzi, R Stefanov Rare Diseases Epidemiology, 475-491, 2010 | 62 | 2010 |
| National registries of rare diseases in Europe: an overview of the current situation and experiences D Taruscio, L Vittozzi, R Choquet, K Heimdal, G Iskrov, Y Kodra, ... Public health genomics 18 (1), 20-25, 2015 | 55 | 2015 |
| Multi-criteria decision analysis for assessment and appraisal of orphan drugs G Iskrov, T Miteva-Katrandzhieva, R Stefanov Frontiers in Public Health 4, 214, 2016 | 50 | 2016 |
| Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study R Linertová, P Serrano-Aguilar, M Posada-de-la-Paz, M Hens-Pérez, ... Health policy 108 (1), 19-26, 2012 | 46 | 2012 |
| Challenges to orphan drugs access in Eastern Europe: the case of Bulgaria G Iskrov, T Miteva-Katrandzhieva, R Stefanov health policy 108 (1), 10-18, 2012 | 45 | 2012 |
| General knowledge and awareness on rare diseases among general practitioners in Bulgaria. M Ts, R Jordanova, G Iskrov, R Stefanov Georgian medical news, 16-19, 2011 | 38 | 2011 |
| International Registry of Recurrent and Familial HUS/TTP. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic … E Bresin, E Daina, M Noris, F Castelletti, R Stefanov, P Hill, TH Goodship, ... Clin J Am Soc Nephrol 1 (1), 88-99, 2006 | 37 | 2006 |
| Real-world experiences in autistic adult diagnostic services and post-diagnostic support and alignment with services guidelines: Results from the ASDEU study ML Scattoni, M Micai, A Ciaramella, T Salvitti, F Fulceri, LM Fatta, ... Journal of Autism and Developmental Disorders, 1-18, 2021 | 36 | 2021 |
| Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations G Iskrov, R Stefanov Orphan Drugs: Research and Reviews, 1-9, 2014 | 34 | 2014 |
| Interobserver agreement in diagnosing liver involvement in hereditary hemorrhagic telangiectasia by Doppler ultrasound E Buscarini, M Gebel, K Ocran, G Manfredi, GDV Blanco, R Stefanov, ... Ultrasound in medicine & biology 34 (5), 718-725, 2008 | 28 | 2008 |
| Economic burden and health-related quality of life of patients with cystic fibrosis in Bulgaria GG Iskrov, RS Stefanov, J López-Bastida, R Linertová, J Oliva-Moreno, ... Medical University Plovdiv (Bulgaria), 2015 | 27 | 2015 |
| Access to orphan drugs–comparison across Balkan countries AV Pejcic, G Iskrov, MM Jakovljevic, R Stefanov Health Policy 122 (6), 583-589, 2018 | 25 | 2018 |
| Criteria for drug reimbursement decision-making: an emerging public health challenge in Bulgaria G Iskrov, R Stefanov Balkan Medical Journal 33 (1), 27-35, 2016 | 23 | 2016 |
| EUROPLAN: a project to support the development of national plans on rare diseases in Europe D Taruscio, AE Gentile, M De Santis, RM Ferrelli, M Posada de la Paz, ... Public Health Genomics 16 (6), 278-287, 2014 | 23 | 2014 |
| Evaluation of diagnostic and prognostic value of clinical characteristics of Migraine and Tension type headache included in the diagnostic criteria for children and adolescents … I Pacheva, I Milanov, I Ivanov, R Stefanov International journal of clinical practice 66 (12), 1168-1177, 2012 | 23 | 2012 |
| Tackling rare diseases at European level: why do we need a harmonized framework D Taruscio, A Trama, R Stefanov Folia Med 49 (1-2), 59-67, 2007 | 22 | 2007 |
| Social/economic costs and health-related quality of life in patients with histiocytosis in Europe G Iskrov, I Astigarraga, R Stefanov, J López-Bastida, R Linertová, ... The European Journal of Health Economics 17, 67-78, 2016 | 21 | 2016 |
| Insight into reimbursement decision-making criteria in Bulgaria: implications for orphan drugs GG Iskrov, RD Raycheva, RS Stefanov Folia medica 55 (3/4), 80, 2013 | 21 | 2013 |
Georgi IskrovMedical University of Plovdiv (Bulgaria) | Institute for Rare Diseases (Bulgaria)在 raredis.org 的电子邮件经过验证
